Cross Berry Pharmaceuticals Private Limited

Cross Berry Pharmaceuticals Private Limited - chemicals in Kolhapur, Maharashtra, India. FY 2026 financials & compliance.
CIN U33125PN2014PTC150609 Incorporated 13 February 2014 ROC Pune HQ Kolhapur, Maharashtra, India
Active Private Limited Company chemicals
Revenue · FY 2020
₹69.6 Lakh
▲ 50% YoY
Net profit · FY 2020
₹41,276
Net margin 0.6%
EBITDA · FY 2020
₹2.39 Lakh
EBITDA margin 3.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.4 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Satisfied ₹8 Lakh
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings

About Cross Berry Pharmaceuticals Private Limited

Data last updated:

Cross Berry Pharmaceuticals Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 13 February 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33125PN2014PTC150609. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.4 Lakh. It is led by directors Ashalata Deepak Wadakar and Deepak Anandarao Wadkar.

Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Kolhapur, Maharashtra.

As per the financials filed for FY 2020, the company reported a revenue of ₹69.6 Lakh, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹41,276 (net margin 0.6%) and EBITDA of ₹2.39 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 43% over five years.

As per MCA filings, the company has open charges of ₹20 Lakh and satisfied charges of ₹8 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U33125PN2014PTC150609
Registration Number 150609
Incorporation Date 13 February 2014
ROC Pune
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Cross Berry Pharmaceuticals Private Limited's registered office is in Kolhapur, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1016 Plot No 20 B Bhoite Nagar Near Dugadha Cooperative Housing Society Saneguruji, Vasahat, Kolhapur, Maharashtra, India – 416012
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products

To see the full contact details of Cross Berry Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Cross Berry Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Cross Berry Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Cross Berry Pharmaceuticals Private Limited, buy the company report.

Financials of Cross Berry Pharmaceuticals Private Limited

FY 2020 filings available

Cross Berry Pharmaceuticals Private Limited reported revenue of ₹69.6 Lakh (up 50% YoY) for FY 2020.

Revenue · FY 2020
₹69.6 Lakh ▲ 50%
Net profit · FY 2020
₹41,276 margin 0.6%
EBITDA · FY 2020
₹2.39 Lakh margin 3.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 40%
5 years · compounded
▲ 43%
EBITDA CAGR growth
1 year
▲ 157%
3 years · compounded
▲ 39%
5 years · compounded
▲ 80%

Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 50% growth in the latest year. EBITDA rose 157% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.39 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹41,276
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin3.4%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cross Berry Pharmaceuticals Private Limited, buy the company report.

Board of directors of Cross Berry Pharmaceuticals Private Limited

Cross Berry Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashalata Deepak WadakarDirector25 Feb 20215 Years 8 MonthsCurrent
Deepak Anandarao WadkarDirector26 Jul 20197 Years 3 MonthsCurrent

Peer comparison

Cross Berry Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Hahnemann Pharmaceuticals Private Limited₹70.46 Lakh (FY 2024)28.0%New Delhi, Delhi, India
Cross Berry Pharmaceuticals Private Limitedthis company₹69.6 Lakh (FY 2020)₹41,2760.6%50.0%Kolhapur, Maharashtra, India
Deemar Pharmaceuticals Private Limited₹69.5 Lakh (FY 2025)46233.0%Hyderabad, Telangana, India
Medcorpus Pharmaceuticals Private Limited₹69.28 Lakh (FY 2025)4.0%Kolathur, Tamil Nadu, India

To see the full peer comparison of Cross Berry Pharmaceuticals Private Limited, buy the company report.

Auditor

Cross Berry Pharmaceuticals Private Limited is audited by RAM S PATIL & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
RAM S PATIL & ASSOCIATESFY 2017135893

Shareholding

The shareholding of Cross Berry Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cross Berry Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹20 Lakh
Satisfied charges
₹8 Lakh
Breakdown by lending institutions
Others₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
21 Jan 2022100529723Others₹20 LakhOpen
28 Dec 2017100150910Bank of India₹8 LakhSatisfied

To see the full charge records of Cross Berry Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Cross Berry Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Cross Berry Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Cross Berry Pharmaceuticals Private Limited, buy the company report.

Recent activity

Cross Berry Pharmaceuticals Private Limited has 6 board changes on record since 2019: 2 appointments and 4 cessations. The latest: Mohan Ramchandra Barage ceased to be Director on 26 Feb 2021.

Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 100529723 was registered on 21 Jan 2022.
Charges
A charge registered on 28 Dec 2017 via Charge ID 100150910 with Bank Of India was fully satisfied on 17 Jan 2022.
Ceased
Mohan Ramchandra Barage ceased to be Director.
Appointed
Ashalata Deepak Wadakar was appointed as Director.
AGM
Cross Berry Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records.
Filing
Cross Berry Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune.
Ceased
Deepak Anandarao Wadkar ceased to be Additional Director.
Ceased
Dipak Ekanath Shinde ceased to be Additional Director.
Appointed
Deepak Anandarao Wadkar was appointed as Director.
Ceased
Ramchandra Dattatray Barage ceased to be Director.
Charges
A charge with Bank Of India amounted to Rs. 8.00 Lakh with Charge ID 100150910 was registered on 28 Dec 2017.
Incorporation
13 Feb 2014
Cross Berry Pharmaceuticals Private Limited was registered on 13 Feb 2014 with Roc Pune & aged 12 years 9 months as per MCA records.

Frequently asked questions

Cross Berry Pharmaceuticals is an active private limited company based in Kolhapur, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 13 February 2014 (12+ years old) and is registered under CIN U33125PN2014PTC150609.

Cross Berry Pharmaceuticals has 2 current directors:

The latest financial statements of Cross Berry Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 December 2020. Year-wise statements from 2015 are in the company report.

No. Cross Berry Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Cross Berry Pharmaceuticals is U33125PN2014PTC150609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cross Berry Pharmaceuticals was incorporated on 13 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Pune.

The peers of Cross Berry Pharmaceuticals by revenue are Hahnemann Pharmaceuticals Private Limited, Deemar Pharmaceuticals Private Limited, Medcorpus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mohan Ramchandra Barage ceased to be Director on 26 Feb 2021. Ashalata Deepak Wadakar was appointed as Director on 25 Feb 2021. Deepak Anandarao Wadkar ceased to be Additional Director on 30 Sep 2019. Cross Berry Pharmaceuticals has 6 board changes on record in total.

The registered office of Cross Berry Pharmaceuticals is at 1016 Plot No 20 B Bhoite Nagar Near Dugadha Cooperative Housing Society Saneguruji, Vasahat, Kolhapur, Maharashtra, India – 416012.

Cross Berry Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.

Cross Berry Pharmaceuticals has open charges of ₹20 Lakh and satisfied charges of ₹8 Lakh as per latest MCA filings.